mdm2 mRNA Level is a Prognostic Factor in Soft Tissue Sarcoma

被引：0
|
作者：
Helge Taubert
Thomas Koehler
Axel Meye
Frank Bartel
Christiane Lautenschläger
Silke Borchert
Matthias Bache
Hannelore Schmidt
Peter Würl
机构：
[1] Martin-Luther-University of Halle-Wittenberg,Institute of Pathology
[2] Martin-Luther-University of Halle-Wittenberg,Institute of Medical Biometry and Informatics
[3] Martin-Luther-University of Halle-Wittenberg,Department of Radiotherapy
[4] University of Leipzig,Department of Clinical Chemistry and Pathobiochemistry, Division of Molecular Biology
[5] University of Leipzig,Clinic of Surgery 1
来源：
Molecular Medicine | 2000年 / 6卷
关键词：
Mdm2 mRNA Expression; Soft Tissue Sarcomas (STS); Gene Therapeutic Approaches; MDM2 Protein; Integrated Separation Systems;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：50 / 59
页数：9
相关论文
共 50 条
  • [41] P53 MUTATION AND MDM2 AMPLIFICATION IN HUMAN SOFT-TISSUE SARCOMAS
    LEACH, FS
    TOKINO, T
    MELTZER, P
    BURRELL, M
    OLINER, JD
    SMITH, S
    HILL, DE
    SIDRANSKY, D
    KINZLER, KW
    VOGELSTEIN, B
    CANCER RESEARCH, 1993, 53 (10) : 2231 - 2234
  • [42] PROGNOSTIC FACTORS IN SOFT-TISSUE SARCOMA
    WESTBURY, G
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1992, 74 (04): : 486 - 487
  • [43] Staging and prognostic factors in soft tissue sarcoma
    Pisters, PWT
    Pollock, RE
    SEMINARS IN RADIATION ONCOLOGY, 1999, 9 (04) : 307 - 314
  • [44] Alternative and aberrant splicing of MDM2 mRNA in human cancer
    Bartel, F
    Taubert, H
    Harris, LC
    CANCER CELL, 2002, 2 (01) : 9 - 15
  • [45] Pre-Treatment Anemia Is a Poor Prognostic Factor in Soft Tissue Sarcoma Patients
    Szkandera, Joanna
    Gerger, Armin
    Liegl-Atzwanger, Bernadette
    Stotz, Michael
    Samonigg, Hellmut
    Ploner, Ferdinand
    Stojakovic, Tatjana
    Leithner, Andreas
    Pichler, Martin
    PLOS ONE, 2014, 9 (09):
  • [46] MDM2 as an independent prognostic marker in breast carcinoma patients
    Turbin, DA
    Cheang, MCU
    Gelmon, K
    Yorida, E
    Nielson, TO
    Gilks, CB
    Huntsman, DG
    MODERN PATHOLOGY, 2005, 18 : 53A - 53A
  • [47] MDM2 as an independent prognostic marker in breast carcinoma patients
    Turbin, DA
    Cheang, MCU
    Gelmon, K
    Yorida, E
    Nielsen, TO
    Gilks, CB
    Huntsman, DG
    LABORATORY INVESTIGATION, 2005, 85 : 53A - 53A
  • [48] Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patientsInverse Korrelation von ErbB2-mRNA und der Proteinexpression in Weichteilsarkompatienten
    Henri Wichmann
    Antje Güttler
    Matthias Bache
    Helge Taubert
    Martina Vetter
    Peter Würl
    Hans J. Holzhausen
    Alexander W. Eckert
    Matthias Kappler
    Dirk Vordermark
    Strahlentherapie und Onkologie, 2014, 190 : 912 - 918
  • [49] MOLECULAR ABNORMALITIES OF MDM2 AND P53 GENES IN ADULT SOFT-TISSUE SARCOMAS
    CORDONCARDO, C
    LATRES, E
    DROBNJAK, M
    OLIVA, MR
    POLLACK, D
    WOODRUFF, JM
    MARECHAL, V
    CHEN, JD
    BRENNAN, MF
    LEVINE, AJ
    CANCER RESEARCH, 1994, 54 (03) : 794 - 799
  • [50] MDM2 is a useful prognostic biomarker for resectable gastric cancer
    Ye, Yang
    Li, Xuan
    Yang, Jingjing
    Miao, Shuhan
    Wang, Shouyu
    Chen, Yansu
    Xia, Xiaowei
    Wu, Xuming
    Zhang, Jianbing
    Zhou, Yan
    He, Song
    Tan, Yongfei
    Qiang, Fulin
    Li, Gang
    Roe, Oluf Dimitri
    Zhou, Jianwei
    CANCER SCIENCE, 2013, 104 (05) : 590 - 598
12345